Avoidance of Toxoplasma gondii transmission from a recently infected donor to the recipient of hematopoietic stem cell transplantation.
Brenier-Pinchart
M P
MP
Garban
F
F
Fricker-Hidalgo
H
H
Richard
M J
MJ
Makowski
C
C
Pelloux
H
H
D000328:Adult; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D015572:Spiramycin / Q000627:therapeutic use; D014019:Tissue Donors; D014123:Toxoplasmosis / Q000517:prevention & control* / Q000635:transmission; D014184:Transplantation, Homologous
D015572:Spiramycin